SCHEMBL7992745

SCHEMBL7992745

COc1ccc2c(C(=O)C(=O)N(CC(=O)N(C(C)C)C(C)C)CC3CCCCC3)c[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
ALDH1A1 P00352 5/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
BCHE P06276 2/20 0.45
ACHE P22303 2/20 0.45
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TUBB1 Q9H4B7 2/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3122360 0.89 ALDH1A1 (0.59) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL7992052 0.89 ALDH1A1 (0.55) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL7948285 0.88 ALDH1A1 (0.58) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL3129608 0.88 MAPT (0.58) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL3124609 0.88 ALDH1A1 (0.55) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL4315114 0.86 MAPT (0.54) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL7945127 0.86 MAPT (0.57) MAPTALDH1A1L3MBTL1BCHEACHE
SCHEMBL7949180 0.85 ALDH1A1 (0.55) MAPTALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL7985731 0.85 MAPT (0.55) MAPTALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL3119104 0.85 MAPT (0.55) MAPTALDH1A1L3MBTL1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed